VLRS:NYSEControladora Vuela Compania de Aviacion, S.A.B. de C.V. Analysis
Data as of 2026-09-15 - not real-time
$6.42
Latest Price
9/10Risk
Risk Level: High
Executive Summary
At $6.42, Controladora Vuela Compañía de Aviación, S.A.B. de C.V. shows a bearish moving-average alignment, with shorter averages beneath longer ones. The last 30 days have lost 18.0%. RSI sits at 34.1, which reads as approaching oversold, and MACD momentum is bullish. Recent trading has carved out support near $6.29 and resistance around $7.85.
The company is not currently profitable on a trailing basis, so earnings multiples offer no valuation support. The average analyst target implies 47.4% above today's level. Revenue is growing at 23.9% on a -5.7% profit margin.
Risk comes out at 9 of a possible 10, a high reading. With 30-day volatility of 37.5%, a beta of 1.90 and a maximum drawdown of 42.1%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 91 on the fear-greed composite.
Timeframes disagree: the short-term read is sell while the long-term read is hold, conviction 3 out of 10.
The company is not currently profitable on a trailing basis, so earnings multiples offer no valuation support. The average analyst target implies 47.4% above today's level. Revenue is growing at 23.9% on a -5.7% profit margin.
Risk comes out at 9 of a possible 10, a high reading. With 30-day volatility of 37.5%, a beta of 1.90 and a maximum drawdown of 42.1%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 91 on the fear-greed composite.
Timeframes disagree: the short-term read is sell while the long-term read is hold, conviction 3 out of 10.
Top Market Events
MEXICO CITY, May 06, 2026 GLOBE NEWSWIRE -- Controladora Vuela Compañía de Aviación, S.MEXICO CITY, Aug. 05, 2026 GLOBE NEWSWIRE -- Controladora Vuela Compañía de Aviación, S.A.B. de C.V. NYSE: VLRS and...MEXICO CITY, April 27, 2026 GLOBE NEWSWIRE -- Controladora Vuela Compañía de Aviación, S.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 4/10
Key Factors
- Short-term moving averages stacked below long-term ones
- Trading below the 200-day average of 8.06
- MACD momentum is positive
Medium Term
1–3 yearsCautious
Model confidence: 4/10
Key Factors
- Short-term moving averages stacked below long-term ones
- Trading below the 200-day average of 8.06
- Analyst targets imply +47.4% versus the current price
Long Term
> 3 yearsNeutral
Model confidence: 3/10
Key Factors
- Negative profit margin of -5.7%
- Analyst targets imply +47.4% versus the current price
- Negative return on equity of -116.8%
Key Metrics & Analysis
Financial Health
Revenue Growth23.90%
Profit Margin-5.70%
P/E Ratio-32.3
ROE-116.83%
ROA0.12%
Debt/Equity5717.21
P/B Ratio10.9
Op. Cash Flow$979.9M
Free Cash Flow$429.9M
Industry P/E27.6
Technical Analysis
TrendBearish
RSI34.1
Support$6.29
Resistance$7.85
MA 20$6.82
MA 50$7.56
MA 200$8.06
MACDBullish
VolumeDecreasing
Fear & Greed Index90.89
Valuation
Fair Value$94.07
Target Price$9.46
Upside/Downside47.38%
GradeFair
TypeGrowth
Risk Assessment
Beta1.90
Volatility37.54%
Sector RiskMedium
Reg. RiskMedium
Geo RiskHigh
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.